Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations
Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines
Gamma Biosciences, a Life Sciences Tool Platform Created by KKR, Has Agreed to Acquire State College, Pennsylvania Based, BioMagnetic Solutions (BMS), a Next-Generation Cell Selection and Bioseparation Technology Company.
Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology
Gamma Biosciences Acquires Nanopareil to Advance Next-Generation Purification Capabilities of Astrea Bioseparations
Launch of Univercells Technologies for intensified, automated technologies
KKR Forms Life Sciences Tools Platform Gamma Biosciences
Astrea arises from the Prometic ashes; inks column deal with Thermo
Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership.
Biotech Week Boston
The Biotech event accelerating fresh ideas, partnerships and opportunities
ARM Meeting on the Mesa
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures